TB Is Still Rife Fifty Years After The Study Which Found A Cure

October 29, 1998

Tuberculosis: story or medical failure?

In a week when the world of medicine is celebrating the 50th anniversary of the first randomised controlled trial, Chris Holme, journalist at the Herald newspaper in Glasgow, laments the irony that half a century on, the disease that this trial found the means to eradicate, is still rife.

The MRC trial, which was published in the BMJ on 30 October 1948, found Streptomycin to be an effective treatment of tuberculosis. In a stinging attack in this week's BMJ, the author writes that despite the results of this trial there has been a failure to implement treatment regimens, which has led to an international resurgence of the disease.

The author details the path of complacency that he believes has led to the epidemic we are now witnessing in the 1990s and asks: "why after an estimated one million controlled trials on every treatment under the sun, have we failed to apply the results of the initial ones on tuberculosis chemotherapy?"


Contact:

Chris Holme, Herald, Glasgow, Scotland

(Contact through Jill Shepherd at BMJ press office Wednesday 28 - Friday 30 October)
-end-


BMJ

Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.